The aberrant expression and dysregulation of AMBRA1 positively and negatively control tumor formation and progression through diverse signal pathways, such as c-MYC, cyclin D, mTOR, PI3K, STAT3, and TGFβ (21, 23, 24, 26, 34, 38). The gene discussed is STAT3; the disease is neoplasm.